Interparfums, Inc. (IPAR)
(Delayed Data from NSDQ)
$121.69 USD
+0.62 (0.51%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $121.49 -0.20 (-0.16%) 7:58 PM ET
1-Strong Buy of 5 1
D Value B Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$121.69 USD
+0.62 (0.51%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $121.49 -0.20 (-0.16%) 7:58 PM ET
1-Strong Buy of 5 1
D Value B Growth D Momentum C VGM
Zacks News
Check Out Avon's (AVP) Probability to Beat Earnings in Q2
by Zacks Equity Research
Avon's (AVP) Open Up strategy is likely to drive second-quarter 2019 results. However, its soft Representatives growth and adverse currency remain deterrents.
Why Procter & Gamble (PG) is Poised to Beat on Q4 Earnings
by Zacks Equity Research
Procter & Gamble's (PG) fourth-quarter fiscal 2019 results are set to gain from ongoing productivity efforts, robust organic growth, higher shipment volume and favorable price/mix.
Will Inter Parfums (IPAR) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Inter Parfums (IPAR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
NUS or IPAR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
NUS vs. IPAR: Which Stock Is the Better Value Option?
HELE or IPAR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
HELE vs. IPAR: Which Stock Is the Better Value Option?
HELE vs. IPAR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
HELE vs. IPAR: Which Stock Is the Better Value Option?
Inter Parfums (IPAR) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Inter Parfums (IPAR) delivered earnings and revenue surprises of 5.26% and 0.02%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Tyson Foods (TSN) Q2 Earnings Beat Estimates, Sales Improve
by Zacks Equity Research
Tyson Foods (TSN) second-quarter fiscal 2019 results gain from growth in beef and chicken categories.
TreeHouse (THS) Q1 Earnings Beat Estimates, Sales Decline
by Zacks Equity Research
TreeHouse (THS) continues to witness adverse impacts from divestiture and SKU rationalization in Q1.
Kellogg (K) Q1 Earnings Beat Estimates, Buyout Boosts Sales
by Zacks Equity Research
Kellogg (K) first-quarter 2019 earnings decline year over year, while sales improve on the back of acquisitions.
Avon (AVP) Q1 Earnings Beat Estimates, Sales Miss Hurts Stock
by Zacks Equity Research
Avon's (AVP) Q1 earnings gain from strong operating margin growth and effective execution of the Open Up strategy. However, soft Representatives across segments and adverse currency hurt the top line.
Pilgrim's Pride (PPC) Misses on Q1 Earnings and Revenues
by Zacks Equity Research
Pilgrim's Pride's (PPC) Q1 results hurt by tough chicken market in Mexico and high input costs in Europe.
Estee Lauder (EL) Q3 Earnings & Sales Beat, Outlook Raised
by Zacks Equity Research
Estee Lauder's (EL) top and bottom lines improve year over year and surpass estimates in Q3. The company continues to gain from strength in most categories.
Mondelez's (MDLZ) Q1 Earnings Beat Estimates, Sales Decline
by Zacks Equity Research
Gains from pricing support Mondelez's (MDLZ) Q1 results. However, adverse currency impact is a drag on top line.
Can Cost Inflation Weigh on Tyson Foods' (TSN) Q2 Earnings?
by Zacks Equity Research
Tyson Foods (TSN) Q1 results to gain from strength in chicken and beef categories. However, rising input costs and sluggish pork unit are concerns.
Medifast's (MED) Q1 Earnings to Gain From OPTAVIA Brands
by Zacks Equity Research
Sturdy growth in the OPTAVIA banner is likely to boost Medifast's (MED) Q1 results. However, rising freight and SG&A expenses are concerns.
Will Chicken Woes Linger in Pilgrim's Pride (PPC) Q1 Earnings?
by Zacks Equity Research
Pilgrim's Pride (PPC) Q1 results is likely to be hurt by volatility in commodity chicken market. Nevertheless, strength in the Prepared Food unit bodes well.
Estee Lauder (EL) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Estee Lauder (EL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Is Disappointment in Store for B&G Foods (BGS) in Q1 Earnings?
by Zacks Equity Research
B&G Foods' (BGS) margins are under pressure due to increased freight costs. Also, Pirate Brands' divestiture is likely to weigh on sales in Q1, though buyouts should offer some cushion to the stock.
Factors to Watch Ahead of Hanesbrands' (HBI) Q1 Earnings
by Zacks Equity Research
Hanesbrands (HBI) is likely to witness organic sales growth in Q1. However, raw-material inflation is a threat.
Will High Costs & Weak Units Hurt Kellogg's (K) Q1 Earnings?
by Zacks Equity Research
Rising input costs, currency headwinds and weak units are likely to dent Kellogg's (K) Q1 performance.
Organic Sales to Drive Church & Dwight (CHD) in Q1 Earnings
by Zacks Equity Research
Church & Dwight's (CHD) first-quarter 2019 results are set to gain on organic sales growth. Also, acquisitions are likely to serve as tailwinds, while high costs are a concern.
Factors Likely to Decide Avon's (AVP) Fate in Q1 Earnings
by Zacks Equity Research
Soft Representatives growth and currency headwind are likely to mar Avon's (AVP) Q1 results. However, the Open Up Avon strategy may bring some respite.
Will Mondelez (MDLZ) Post Q1 Earnings Beat Amid Hurdles?
by Zacks Equity Research
Mondelez's (MDLZ) Q1 earnings to gain from savings efforts. However, high input costs and adverse currency rates are concerns.
Estee Lauder (EL) to Post Q3 Earnings: Is a Beat in Store?
by Zacks Equity Research
Estee Lauder's (EL) third-quarter fiscal 2019 results are set to gain on strong travel retail network, buyouts and opportunities in the global prestige beauty industry, among other factors.